Filing Details
- Accession Number:
- 0001437749-22-010726
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-05-03 19:12:16
- Reporting Period:
- 2022-04-10
- Accepted Time:
- 2022-05-03 19:12:16
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 810509 | Navidea Biopharmaceuticals Inc. | NAVB | In Vitro & In Vivo Diagnostic Substances (2835) | 311080091 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1753763 | Jr. K John Scott | 4995 Bradenton Ave., Suite 240 Dublin OH 43017 | Yes | No | Yes | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2022-04-30 | 2,500 | $0.00 | 8,093,395 | No | 4 | A | Direct | |
| Series G Redeemable Preferred Stock | Acquisiton | 2022-04-10 | 3,260 | $0.00 | 3,260 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | A | Direct | |
| No | 4 | P | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Series E Redeemable Convertible Preferred Stock | Disposition | 2022-04-10 | 50,000 | $2.30 | 2,173,913 | $2.30 |
| Common Stock | Series F Redeemable Convertible Preferred Stock | Acquisiton | 2022-04-10 | 1,740 | $0.80 | 2,175,000 | $0.80 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2021-03-02 | 2022-09-02 | No | 4 | S | Direct |
| 1,740 | 2022-04-10 | No | 4 | P | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 10,139 | Indirect | By spouse and children |
Footnotes
- Stock issued under the Amended and Restated 2014 Stock Incentive Plan in partial payment of monthly non-employee director fees.
- Issuance deferred at the request of the Reporting Person.
- Includes 2,639 shares of Common Stock owned by the Reporting Person's spouse and 7,500 shares of Common Stock owned by the Reporting Person's children. The Reporting Person may be deemed to have shared voting and/or dispositive power with respect to such shares.
- Series E Redeemable Convertible Preferred Stock, par value $.001 per share, was exchanged for Series F Redeemable Convertible Preferred Stock, par value $.001 per share, and Series G Redeemable Preferred Stock, par value $.001 per share.
- Series F Redeemable Convertible Preferred Stock, par value $.001 per share, is convertible at any time and has no expiration date.
Billionaire Hedge Funds
